Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Reasons Bryan M. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Paid exercise price by delivering 15,976 shares @ $0.693, valued at $11.1k
07/05/2023 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Disposed/sold 168,237 restricted stock units @ $0
06/05/2023 4 Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 15,750 options to buy @ $8.7, valued at $137k
Granted 4,660 restricted stock units @ $0
Exercised 4,507 restricted stock units @ $0
05/19/2023 4 Reasons Bryan M. (Director) has filed a Form 4 on Societal CDMO, Inc.
Txns: Granted 73,620 shares @ $0
Granted 27,229 options to buy @ $0.74, valued at $20.1k
04/05/2023 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Granted 168,237 restricted stock units @ $0
12/22/2022 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Granted 112,636 shares @ $0
06/21/2022 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Disposed/sold 11,593 shares @ $0
Disposed/sold 57,569 options to buy @ $22.26, valued at $1.3M
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Reasons Bryan M. (Director) has filed a Form 4 on Societal CDMO, Inc.
Txns: Granted 87,500 shares @ $0
Granted 118,182 options to buy @ $0.8, valued at $94.5k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2021 4/A Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 38,012 options to buy @ $0
04/22/2021 4 Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 26,923 shares @ $0
Granted 38,012 options to buy @ $1.71, valued at $65k
12/07/2020 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Sold 5,400 shares @ $0.165, valued at $891
06/08/2020 4 Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.41, valued at $23.3k
Exercised 7,333 restricted stock units @ $0
05/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2020 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Paid exercise price by delivering 986 shares @ $1.93, valued at $1.9k
03/04/2020 4 Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 8,876 restricted stock units @ $0
Exercised 8,876 restricted stock units @ $0
12/09/2019 4 Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 9,156 shares @ $0
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Bought 5,400 shares @ $8.9599, valued at $48.4k
05/10/2019 4 Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 7,955 shares @ $0
Granted 10,888 options to buy @ $8.8, valued at $95.8k
04/03/2019 4 Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc
Txns: Granted 12,579 shares @ $0
Granted 57,569 options to buy @ $22.26, valued at $1.3M
03/21/2019 3 Reasons Bryan M. (EVP & CFO) has filed a Form 3 on Mallinckrodt plc
08/23/2018 4 Reasons Bryan M. (CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Sold 11,698 shares @ $23.65, valued at $276.7k
05/14/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/10/2018 4/A Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 8,965 options to buy @ $11.32, valued at $101.5k
05/08/2018 4 Reasons Bryan M. (CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 94,684 shares @ $0
Granted 56,232 options @ $9.35, valued at $525.8k
Granted 63,095 options @ $33.27, valued at $2.1M
Granted 47,500 options @ $40.7, valued at $1.9M
Granted 55,000 options @ $25.24, valued at $1.4M
Granted 52,000 options @ $17.99, valued at $935.5k
Granted 136,240 options @ $15.01, valued at $2M
Granted 33,311 restricted stock units @ $0
05/08/2018 3 Reasons Bryan M. (CFO) has filed a Form 3 on Amneal Pharmaceuticals, Inc.
05/08/2018 4 Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns: Granted 6,183 shares @ $0
Granted 5,742 options to buy @ $11.32, valued at $65k
05/08/2018 4 Reasons Bryan M. (CFO) has filed a Form 4 on Impax Laboratories, LLC
Txns: Disposed/sold 53,423 shares @ $0
Disposed/sold 20,566 shares @ $0
Disposed/sold 56,232 options to buy @ $9.35, valued at $525.8k
Disposed/sold 63,095 options to buy @ $33.27, valued at $2.1M
Disposed/sold 47,500 options to buy @ $40.7, valued at $1.9M
Disposed/sold 55,000 options to buy @ $25.24, valued at $1.4M
Disposed/sold 52,000 options to buy @ $17.99, valued at $935.5k
04/23/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/23/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
03/05/2018 4 Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC
Txns: Paid exercise price by delivering 3,069 shares @ $19.5, valued at $59.8k
02/27/2018 4 Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC
Txns: Paid exercise price by delivering 6,141 shares @ $20.95, valued at $128.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy